Search

Search Results
Results 931 - 940 of 7705 for stem cell therapy
  • News - 26 Apr 2004
    Injections of adult stem cells into damaged heart tissue significantly improved heart function in patients with severe congestive heart failure, according to results of the first prospective...
  • Industry Focus eBook - 8 Jan 2026
    Unlock reliable tools and support for mesenchymal stem cell research and culture, designed to streamline workflows and ensure consistent performance.
  • Health - 27 Feb 2019
    Multiple system atrophy (MSA) is a serious neurodegenerative disease with no available disease-altering therapies and no cure. Its natural history covers a 6 to 9 year course, during which the disease...
  • Health - 10 Jul 2024
    Parkinson’s disease is not yet curable. Several classes of drugs have been found that reduce the symptoms. Numerous researchers are working towards understanding the pathophysiology and developing new...
  • Health - 29 Dec 2022
    The treatment of relapsed or refractory follicular lymphoma (RRFL) is distinct from patients who are receiving treatment for the first time, due to differences in the nature of the disease.
  • News - 3 Oct 2021
    Most strokes happen when an artery in the brain becomes blocked. Blood flow to the neural tissue stops, and those tissues typically die. Because of the locations of the major arteries in the brain,...
  • News - 10 Jun 2016
    As the promise of using regenerative stem cell therapies draws closer, a consortium of biomedical scientists reports about 30 percent of induced pluripotent stem cells they analyzed from 10 research...
  • News - 11 Jan 2016
    Following a heart attack or other heart trauma, the heart is unable to replace its dead cells. Patients are often left with little option other than heart transplants, which are rarely available, or...
  • News - 31 Aug 2015
    For people with Down syndrome, news from Elixirgen, LLC may brighten their day. The biotechnology company, located in the Science + Technology Park at Johns Hopkins, has outlined one of the best...
  • News - 4 Feb 2015
    Sangamo BioSciences, Inc. announced today that an Investigational New Drug (IND) application for the company's SB-BCLmR-HSPC genome editing approach, which is designed to provide a one-time lasting...

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.